Skip to main content
. 2023 Oct 24;23:718. doi: 10.1186/s12879-023-08297-7

Table 1.

Characteristics of patients at baseline

Interventional cohort Observational cohort P-value
N Median (IQR) or n (%) N Mean (95% CI) or n (%)
Age [years] 98 61 (49, 71) 203 66 (56, 77)  < 0.001
Sex 98 203
Female 29 (29.6%) 86 (42.4%) 0.03
Male 69 (70.4%) 117 (57.6%)
Body weight [kg] 96 80 (74, 90) 163 76 (68, 85) 0.004
Height [m]a 91 1.72 (1.70, 1.74) 150 1.69 (1.68, 1.71) 0.02
BMI [kg/m2]a 91 27.1 (25.3, 30.8) 148 26.3 (24.2, 28.6) 0.005
Charlson index 97 2 (1, 3) 203 3 (1, 5)  < 0.001
Diabetes mellitus 98 13 (13.3%) 203 35 (17.2%) 0.41
COPD 98 5 (5.1%) 203 23 (11.3%) 0.09
Obesity 98 25 (25.5%) 180 29 (16.1%) 0.08
Hypertension 96 36 (37.5%) 203 114 (56.2%) 0.003
Smoking 96 5 (5.2%) 203 9 (4.4%) 0.77
Vaping cigarettes user 5 1 (20.0%) 7 0 (0.0%) 0.42
Alcoholism 96 3 (3.1%) 203 2 (1.0%) 0.33
Active opioid use 96 1 (1.0%) 203 0 (0.0%) 0.32
Haemodialysis 96 0 (0.0%) 203 0 (0.0%) n/a
Immunocompromised 97 0 (0.0%) 203 7 (3.4%) 0.10

Bold: values used in Propensity Score Matching

aMean and 95% CI are reported and p-value was obtained from t-test for independent samples